Vertex Pharmaceuticals Incorporated vs Lockheed Martin
Confronto della capitalizzazione di mercato nel tempo
Vertex Pharmaceuticals Incorporated
$132.8B
Posizione #123
Lockheed Martin
$139.6B
Posizione #118
Capitalizzazione di mercato nel tempo
Momenti chiave
- Vertex Pharmaceuticals Incorporated ha superato Lockheed Martin entro il 1996
- Lockheed Martin ha superato Vertex Pharmaceuticals Incorporated entro il 1997
- Vertex Pharmaceuticals Incorporated ha superato Lockheed Martin entro il 1999
- Lockheed Martin ha superato Vertex Pharmaceuticals Incorporated entro il 2002
- Vertex Pharmaceuticals Incorporated ha superato Lockheed Martin entro il 2009
- Lockheed Martin ha superato Vertex Pharmaceuticals Incorporated entro il 2010
- Vertex Pharmaceuticals Incorporated ha superato Lockheed Martin entro il 2023
- Lockheed Martin ha superato Vertex Pharmaceuticals Incorporated entro il 2024
- Vertex Pharmaceuticals Incorporated ha superato Lockheed Martin entro il 2025
- Lockheed Martin ha superato Vertex Pharmaceuticals Incorporated entro il 2026
Confronto anno per anno
| Anno | Vertex Pharmaceuticals Incorporated | Lockheed Martin | Leader |
|---|---|---|---|
| 2026 | $132.8B | $139.6B | Lockheed Martin |
| 2025 | $115.1B | $109.4B | Vertex Pharmaceuticals Incorporated |
| 2024 | $102.2B | $106.9B | Lockheed Martin |
| 2023 | $103.3B | $97.8B | Vertex Pharmaceuticals Incorporated |
| 2022 | $73.3B | $102.2B | Lockheed Martin |
| 2021 | $55.7B | $72.7B | Lockheed Martin |
| 2020 | $60.0B | $70.5B | Lockheed Martin |
| 2019 | $55.6B | $75.4B | Lockheed Martin |
| 2018 | $42.1B | $49.4B | Lockheed Martin |
| 2017 | $38.0B | $59.1B | Lockheed Martin |
| 2016 | $18.7B | $44.8B | Lockheed Martin |
| 2015 | $31.9B | $37.9B | Lockheed Martin |
| 2014 | $30.2B | $32.6B | Lockheed Martin |
| 2013 | $18.9B | $24.4B | Lockheed Martin |
| 2012 | $10.6B | $14.5B | Lockheed Martin |
| 2011 | $8.4B | $12.1B | Lockheed Martin |
| 2010 | $8.9B | $10.1B | Lockheed Martin |
| 2009 | $10.9B | $10.5B | Vertex Pharmaceuticals Incorporated |
| 2008 | $7.7B | $11.3B | Lockheed Martin |
| 2007 | $5.9B | $13.9B | Lockheed Martin |
| 2006 | $9.5B | $12.0B | Lockheed Martin |
| 2005 | $7.0B | $8.1B | Lockheed Martin |
| 2004 | $2.7B | $7.0B | Lockheed Martin |
| 2003 | $2.6B | $6.4B | Lockheed Martin |
| 2002 | $4.0B | $7.1B | Lockheed Martin |
| 2001 | $6.2B | $5.7B | Vertex Pharmaceuticals Incorporated |
| 2000 | $18.1B | $4.1B | Vertex Pharmaceuticals Incorporated |
| 1999 | $4.4B | $2.6B | Vertex Pharmaceuticals Incorporated |
| 1998 | $3.8B | $4.9B | Lockheed Martin |
| 1997 | $4.2B | $5.6B | Lockheed Martin |
| 1996 | $5.1B | $5.1B | Vertex Pharmaceuticals Incorporated |
| 1995 | $3.4B | $4.3B | Lockheed Martin |
| 1994 | $1.9B | $2.4B | Lockheed Martin |